StartseiteAktuellesBekanntmachungenInnovative Medicines Initiative (IMI): 9. Aufruf zur Einreichung von Projektvorschlägen

Innovative Medicines Initiative (IMI): 9. Aufruf zur Einreichung von Projektvorschlägen

Stichtag: Stichtag für EoIs: 09.10.2013 Programmausschreibungen

On 7 July 2013, IMI officially launched its 9th Call for proposals. Based on the recommendations of the IMI Research Agenda the IMI Governing Board has approved the Scientific Priorities 2013 as part of IMI Annual Implementation Plan 2013. Four of these priorities are implemented through the IMI 9th Call Topics (for Details see Information Package below):

  • WEBAE – Leveraging emerging technologies for pharmacovigilance
  • Developing innovative therapeutic interventions against physical frailty and sarcopenia (ITI-PF&S) as a prototype geriatric indication
  • Driving re-investment in R&D and responsible use of antibiotics (ND4BB topic 4)
  • Clinical development of antibacterial agents for Gram-negative antibiotic resistant pathogens (ND4BB topic 5) 

Applicants intending to submit an Expression of Interest (EoI) in response to the IMI 9th Call should read the Call topics text, the Rules for Participation in the IMI JU collaborative projects, the Rules for Submission, Evaluation and Selection of EoIs and Full Project Proposals (FPPs), the IMI IPR rules and the IMI JU model Grant Agreement (see Information Package below).

Call Identifier
: IMI-JU-9-2013
Publication Date: 9 July 2013
Submissions start date (for submitting EoIs): 9 July 2013
Submissions deadline (for submitting EoIs): 9 October 2013 – 17:00:00 (CEST)

Budget: The indicative in kind contribution from the research-based companies that are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) will be EUR 72.25 million. The financial contribution from the European Community to the IMI JU for the support of research activities will be a maximum of EUR 63.12 million.

Information Package

the Information Package contains the key documents required for the preparation of your Expression of Interest (EoI):

Restrictions for Participation: see the Rules for Participation in the IMI JU collaborative projects.

Entities eligible to receive funding: see eligibility criteria to receive funding in the Rules for Participation in the IMI JU collaborative projects.

Selection of Expressions of Interest and Full Project Proposals: see Rules for Submission, Evaluation and Selection of Expressions of Interest and Full Project Proposals.

Compliance with ethical issues: information is available on the following internet address: http://cordis.europa.eu/fp7/ethics_en.html

Application form (for submitting EoIs):

Please note: The IMI electronic submission tool SOFIA (Submission OF Information Application) is to be used for submitting an Expression of Interest in response to a topic of the 9th Call; no other means of submission will be accepted. SOFIA was opened for submission of EoIs on 9 July 2013. Updates of the EoIs may be submitted online until the Call submission deadline. Only the most recent version shall be considered for the evaluation procedure (including eligibility check).

To access the IMI electronic submission tool SOFIA, Applicant Consortium Coordinators wishing to submit an expression of interest will need to complete a Request for Access to the tool.

Quelle: Innovative Medicines Initiative Redaktion: von Tim Mörsch, VDI Technologiezentrum GmbH Länder / Organisationen: EU Themen: Lebenswissenschaften Innovation Förderung

Projektträger